Bausch Health Companies 10K 2023 Annual report | BHC Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: abeyance, absorb, acquiree, AcuStream, adjuvant, admission, Advisor, aerosol, Algeria, alia, antagonist, anti, arose, AspireTM, ASU, Authorisation, Beijing, BeyondTM, BHCI, Brent, brighter, CABTREOTM, cardiovascular, Cencora, cephalosporin, CFO, Chair, champion, Chase, Clearwater, codified, concealed, conclusion, CSF, CT, Curia, DC, decompensation, deflation, detrimental, digitalisation, distal, DPF, Dr, DRL, DTC, embedded, EMEA, endoscopic, enterprise, entirety, entrant, EnvyTM, epinephrine, evaporation, flatulence, foam, fractionated, German, GMTA, GP, HHS, hunger, IlluminationsTM, induction, inhibitor, intake, interlocutory, intervened, Inuit, IP, Iran, Jinan, JPMorgan, Kazakhstan, Kelk, kickback, KKR, Lanham, libvatrep, licensee, lifitegrast, lingering, mediation, MEIBO, MIEBO, MNE, modestly, Monday, NIST, noncompetitive, nonpromoted, nuisance, overseen, polymerase, PSU, qui, realleging, recession, reconsider, Recoupment, Reddy, reinforced, resurfacing, ribonucleic, RNA, roadmap, salesforce, Silbersher, soluble, subvert, tam, Tampa, Tecnofarma, Thirteen, threat, tort, ULC, undertaxed, unfunded, unpatentable, warranty, whiter, Woodruff, XIIDRA

Removed: AB, accessibility, Acrux, actinic, Aid, alternate, Amgen, ammonul, antiflatulence, Arzneimittel, ATI, atropine, benzaclin, bepreve, Biogen, Biopharma, bupap, call, candid, caption, cell, centering, chamber, children, clarifying, classifying, clean, clerical, cohesive, commence, composed, consolidating, contemplation, cream, DDS, deep, defer, deferral, demser, dentist, depending, dermatological, disinfectant, dispensing, dissimilar, doctor, dual, dysfunction, edecrin, educational, Eli, emerge, Endo, endothelium, enrolling, Envive, episode, everyday, experiencing, fear, field, fluid, formally, foundation, gained, gave, gland, glycemic, hired, hiring, hospitality, housekeeping, hyposalivation, IBS, incompatible, India, inform, injectable, insured, interbank, intestinal, intraperiod, invalidating, investigated, istalol, isuprel, Jan, Jazz, LIBOR, licensor, Lilly, locoid, London, lubrication, mail, Meibomian, mephyton, metformin, micro, microdose, migranal, misstated, modified, modifying, mouth, moviprep, MPS, mucosa, mutually, netted, neutrasal, noritate, nullity, objector, observed, ocudose, OIC, ointment, online, optimizing, optional, OraPharma, orphan, ortho, outpatient, OVD, overgrowth, overruled, partnership, paused, PCP, pediatric, Perrigo, placebo, plateau, play, positively, postponement, predicted, prefer, preferred, preliminarily, preloaded, probiotic, prolensa, proof, protein, pure, racketeering, ranibizumab, repaying, repricing, resubmission, resumed, resurgence, rinse, salivary, SAR, secretion, serving, showed, SIBO, sickle, speed, STADA, statistically, strongly, submitting, subpoena, surfactant, switching, syndicate, talk, teledermatology, timoptic, trained, transactional, travel, trebled, typical, underwater, unprecedented, unspecified, ValueAct, virazole, Viscosurgical, wire, Xbrane, xerese, xerostomia, Zealand, zegerid, zovirax

Bausch Health Companies (BHC) 10-K2023 FY Annual report

Content analysis